Onyx Pharmaceuticals, Inc., an Amgen subsidiary | 27,319 followers on LinkedIn. Formerly based in South San Francisco, California, Onyx Pharmaceuticals was engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. Amgen acquired Onyx Pharmaceuticals in 2013. See our Community Guidelines: bit.ly/smcgl